Hypothalamic-pituitary suppression with oral contraceptive pills does not improve outcome in poor responder patients undergoing in vitro fertilization-embryo transfer cycles

Journal of Assisted Reproduction and Genetics

Volumn 18, Issue 7, 2001, Pages 391-394

  Kovacs, Peter ^a   Barg, Patricia E ^b   Witt, Barry R ^b  

^a ALBERT EINSTEIN COLLEGE OF MEDICINE   (United States)

^b MONTEFIORE MEDICAL CENTER   (United States)

Author keywords

GnRHa; IVF cycle; OCP; Poor responder

Indexed keywords

ESTRADIOL; FOLLITROPIN; HUMAN MENOPAUSAL GONADOTROPIN; LEUPRORELIN; RECOMBINANT FOLLITROPIN;

ADULT; ARTICLE; EMBRYO TRANSFER; FEMALE; FERTILIZATION IN VITRO; HUMAN; HYPOTHALAMUS HYPOPHYSIS GONAD SYSTEM; INFERTILITY; MAJOR CLINICAL STUDY; ORAL CONTRACEPTION; PREGNANCY RATE; PRIORITY JOURNAL; TREATMENT OUTCOME;

ADULT; CONTRACEPTIVES, ORAL; EMBRYO TRANSFER; FEMALE; FERTILIZATION IN VITRO; GONADOTROPIN-RELEASING HORMONE; HUMANS; HYPOTHALAMUS; INFERTILITY, FEMALE; OOCYTES; OVULATION INDUCTION; PITUITARY GLAND; PREGNANCY; PREGNANCY OUTCOME; RETROSPECTIVE STUDIES;

EID: 0034910667     PISSN: 10580468     EISSN: None     Source Type: Journal    
DOI: 10.1023/A:1016626607387     Document Type: Article

References (17)

1. Cessation of gonadotropin-releasing hormone agonist therapy combined with high-dose gonadotropin stimulation yields favorable pregnancy results in low responders
2. Evaluating strategies for improving ovarian response of the poor responder undergoing assisted reproductive techniques
3. Maximizing pregnancy rates and limiting higher-order multiple conceptions by detemining the optimal number of embryos to transfer based on quality
4. The luteinizing hormone surge - The final stage in ovulation induction: Modern aspects of ovulation triggering
5. Gonadotropin suppression with oral contraceptives before in vitro fertilization
6. Ovarian response in superovulated cycles after suppression with oral contraceptive steroids
7. Results of planned in-vitro fertilization programming through the pre-administration of the oestrogen-progesterone combined pill
8. Effects of pretreatment with an oral contraceptive on the time required to achieve pituitary suppression with gonadotropin-releasing hormone analogues and on subsequent implantation and pregnancy rates
9. Short-term gonadotropin suppression with oral contraceptives benefits poor responders prior to controlled ovarian hyperstimulation
10. The use of oral contraceptives to regulate oocyte retrieval
11. Ovarian response to human menopausal gonadotropin following suppression with oral contraceptives
12. Limited success using the "flare" protocol in poor responders in cycles with low basal follicle-stimulating hormone levels during in vitro fertilization
13. Suppression and flare regimens of gonadotropin-releasing hormone agonist. Use in women with different basal gonadotrpin values in an in vitro fertilization program
14. Follicular atresia associated with concurrent initiation of gonadotropin-releasing hormone agonist and follicle-stimulating hormone for oocyte recruitment
15. High-dose follicle-stimulating hormone stimulation at the onset of the menstrual cycle does not improve the in vitro fertilization outcome in low-responder patients
16. A protocol using a low dose of gonadotropin-releasing hormone agonist might be the best protocol for patients with high follicle-stimulating hormone concentration on day 3
17. Comparison of growth hormone responses to growth hormone-releasing factor and clonidine in women with normal or poor ovarian response to gonadotropin stimulation